SUPN Operating Cash Flow Growth
Supernus Pharmaceuticals Inc · Operating Cash Flow Growth
SUPN Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported-89.36%period ending
SUPN TTM Cash from Operations YoY % (6.95% → -89.36%)
Year-over-year change
High-resolution chart · PNG
SUPN operating cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow Growth |
|---|---|
| -89.3558% | |
| -49.2802% | |
| -72.4741% | |
| -58.3335% | |
| 20.7945% | |
| 63.5602% | |
| 54.7923% | |
| 84.1191% | |
| 116.1101% | |
| -37.9152% | |
| -4.9141% | |
| -32.1203% | |
| -40.3226% | |
| 69.7487% | |
| -8.1029% | |
| 25.1394% | |
| 0.0567% | |
| -42.5234% | |
| -8.1446% | |
| -26.5944% | |
| -34.1769% | |
| 39.1686% | |
| -3.3047% | |
| 13.67% | |
| 16.1419% | |
| -11.7126% | |
| 10.9648% | |
| -0.2151% | |
| 43.9773% | |
| 5.008% | |
| 12.514% | |
| 28.3109% | |
| 17.8985% | |
| 54.1375% | |
| 71.5859% | |
| 67.0382% | |
| 202.3507% | |
| 192.5486% | |
| 107.988% | |
| 222.2019% | |
| -37.5146% | |
| 4.1624% | |
| 315.4015% | |
| 320.9514% | |
| 195.9502% | |
| 145.6961% | |
| 113.3445% | |
| 86.5745% | |
| 15.566% | |
| -10.0747% | |
| -22.7759% | |
| -64.6334% | |
| -62.7826% | |
| -49.1112% | |
| -30.438% | |
| 0.9787% | |
| 6.9504% |